Medicine and Dentistry
Systematic Review
100%
Diabetes
96%
Maturity Onset Diabetes of the Young
64%
Human Immunodeficiency Virus
55%
Cardiovascular Disease
51%
Gestational Diabetes
28%
Insulin Dependent Diabetes Mellitus
25%
Human Immunodeficiency Virus Infection
24%
Meta-Analysis
23%
Personalized Medicine
23%
Cardiovascular Risk
20%
Diabetes Prevention
19%
Clinician
17%
Cohort Analysis
15%
Drug Therapy
15%
Insulin Resistance
15%
Coronary Artery
15%
Patient with Diabetes
14%
Nonalcoholic Fatty Liver
14%
Diabetes Mellitus
14%
Retrovirus Infection
14%
Opportunistic Infection
14%
Medicine
14%
Sodium Glucose Cotransporter 2 Inhibitor
13%
Glycon
13%
Physical Activity
12%
Beta Cell
11%
Glucagon-Like Peptide-1 Agonist
9%
Cross Sectional Study
9%
Disease
9%
Glycemic
8%
Decision Making
8%
Receptor
8%
Lifestyle Intervention
8%
Puerperium
8%
Cardiovascular System
8%
Hemoglobin A1c
8%
Treatment Response
8%
Disease Modifying Therapy
8%
Interleukin-1
8%
Environmental Factor
7%
Isotopes of Calcium
7%
Cardiovascular Disease Prevention
7%
Treatment Effect
7%
Multimodality Imaging
7%
Cannabis Use
7%
Case-Control Study
7%
Endothelial Dysfunction
7%
Insulin Treatment
7%
Glomerular Filtration Rate
7%
Keyphrases
Type 2 Diabetes Mellitus (T2DM)
51%
Cardiovascular Disease
44%
Diabetes
41%
HIV Infection
32%
People Living with HIV (PLHIV)
31%
Cardiovascular Risk
28%
Patients with Diabetes
28%
Meta-analysis
22%
Metabolic
21%
Retroviral Infection
21%
Opportunistic Infections
21%
Type 1 Diabetes Mellitus (T1DM)
21%
Systematic Meta-analysis
21%
Type 2 Diabetes Prevention
20%
Type I Diabetes
19%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
19%
Insulin Resistance
18%
Glucagon-like
15%
A1 Receptor
15%
Receptor Agonist
15%
Stratified Treatment
14%
Monogenic
14%
Genotype
14%
Precision Diagnostics
14%
Gestational Diabetes Mellitus
14%
High Risk
14%
Precision Medicine
12%
Placebo
10%
United States
10%
Comorbidity
10%
Society Guidelines
10%
Antihyperglycemic
9%
Clinical Practice
9%
Cardiovascular Prevention
9%
Estimated Glomerular Filtration Rate
8%
Inflammation
8%
Comorbid Conditions
8%
Established Cardiovascular Disease
8%
Treatment Response
8%
Cardiovascular Effects
8%
GLP-1 Receptor Agonist
8%
Diabetes Management
8%
Disease-modifying Therapy
8%
Multicenter AIDS Cohort Study
8%
Metformin
8%
Lifestyle Intervention
8%
Embase
7%
American Diabetes Association
7%
HIV Status
7%
Cognitive Function
7%